As of 2026-03-23, the EV/EBITDA ratio of Elanco Animal Health Inc (ELAN) is 16.86. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ELAN's latest enterprise value is 15,394.14 mil USD. ELAN's TTM EBITDA according to its financial statements is 913.00 mil USD. Dividing these 2 quantities gives us the above ELAN EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 17.8x | 16.9x |
| Forward P/E multiples | 13.2x - 15.9x | 15.4x |
| Fair Price | 1.07 - 25.67 | 13.24 |
| Upside | -95.6% - 7.0% | -44.8% |
| Date | EV/EBITDA |
| 2026-03-20 | 16.86 |
| 2026-03-19 | 17.48 |
| 2026-03-18 | 17.32 |
| 2026-03-17 | 17.51 |
| 2026-03-16 | 16.55 |
| 2026-03-13 | 16.29 |
| 2026-03-12 | 16.15 |
| 2026-03-11 | 16.57 |
| 2026-03-10 | 16.69 |
| 2026-03-09 | 16.84 |
| 2026-03-06 | 16.52 |
| 2026-03-05 | 16.83 |
| 2026-03-04 | 17.11 |
| 2026-03-03 | 17.35 |
| 2026-03-02 | 18.01 |
| 2026-02-27 | 18.18 |
| 2026-02-26 | 18.06 |
| 2026-02-25 | 18.42 |
| 2026-02-24 | 18.17 |
| 2026-02-23 | 17.28 |
| 2026-02-20 | 17.41 |
| 2026-02-19 | 17.53 |
| 2026-02-18 | 17.30 |
| 2026-02-17 | 17.34 |
| 2026-02-13 | 17.49 |
| 2026-02-12 | 17.30 |
| 2026-02-11 | 17.80 |
| 2026-02-10 | 17.75 |
| 2026-02-09 | 17.32 |
| 2026-02-06 | 17.53 |
| 2026-02-05 | 17.04 |
| 2026-02-04 | 17.09 |
| 2026-02-03 | 17.06 |
| 2026-02-02 | 17.28 |
| 2026-01-30 | 16.92 |
| 2026-01-29 | 16.98 |
| 2026-01-28 | 16.94 |
| 2026-01-27 | 17.21 |
| 2026-01-26 | 17.24 |
| 2026-01-23 | 17.09 |
| 2026-01-22 | 17.37 |
| 2026-01-21 | 17.04 |
| 2026-01-20 | 16.96 |
| 2026-01-16 | 17.16 |
| 2026-01-15 | 16.97 |
| 2026-01-14 | 17.11 |
| 2026-01-13 | 17.12 |
| 2026-01-12 | 16.80 |
| 2026-01-09 | 16.58 |
| 2026-01-08 | 16.46 |